Talk:Bioblast 2022: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
Line 17: | Line 17: | ||
|- | |- | ||
|- | |- | ||
| || || 10:15 || [[Alencar 2022 MitoFit |A unifying hypothesis for the extraordinary energy metabolism of bloodstream Trypanosoma brucei]] || [[Oliveira Marcus F]] | | || || 10:15 || [[Chakrabarti L 2022 Abstract Bioblast|"Going south!” An Antarctic expedition to understand more about mitochondrial haemoglobin and ageing. | ||
]] || [[Chakrabarti Lisa]] | |||
[[Alencar 2022 MitoFit |A unifying hypothesis for the extraordinary energy metabolism of bloodstream Trypanosoma brucei]] || [[Oliveira Marcus F]] | |||
|- | |- | ||
|- | |- | ||
Line 26: | Line 29: | ||
|- | |- | ||
|- | |- | ||
| || || 11:15 || [[ | | || || 11:15 || [[Donnelly 2022 Abstract Bioblast|The ABC of hypoxia – what is the norm?]] || [[Donnelly Chris]] | ||
|- | |- | ||
|- | |- | ||
| || || 11:30 || [[ | | || || 11:30 || [[Schmitt 2022 Abstract Bioblast|Using oxygen and hydrogen gas in studies of mitochondrial respiration and hydrogen peroxide production under hyperoxic, normoxic, and hypoxic conditions]] || [[Schmitt Sabine]] | ||
|- | |- | ||
|- | |- | ||
| || || 11:45 || [[ | | || || 11:45 || [[Hand 2022 Abstract Bioblast|Metabolic shutdown of bioenergetics: Protection of macromolecules and survivorship during stress]] || [[Hand Steven C]] | ||
|- | |- | ||
|- | |- | ||
| || || 12:00 || [[ | | || || 12:00 || [[Roach 2022 Abstract Bioblast |Oxidative stress in photosynthesis]] || [[Roach Thomas]] | ||
|- | |- | ||
|- | |- | ||
| || || 12:15 || [[ | | || || 12:15 || [[Vera Vives 2022 MitoFit |Application of the NextGen-O2k for building photosynthesis-irradiance curves in microalgae. ]] || [[Morosinotto Tomas]] | ||
|- | |- | ||
|- | |- | ||
| '''12:30-14:00''' || '''Lunch Break''' || || || | | '''12:30-14:00''' || '''Lunch Break - Orangerie''' || || || | ||
|- | |- | ||
|- | |- | ||
Line 50: | Line 53: | ||
|- | |- | ||
|- | |- | ||
| || || 14:15 || [[ | | || || 14:15 || [[Heimler 2022 MitoFit|Platelet bioenergetics are associated with resting metabolic rate and exercise capacity in older women]] || [[Molina Anthony JA]] | ||
|- | |- | ||
|- | |- | ||
| || || 14:30 || [[ | | || || 14:30 || [[Granata 2022 Abstract Bioblast |Exercise training-induced enhancement of electron flow to the OXPHOS system is more important than increasing the OXPHOS machinery content to improve ATP generation in human skeletal muscle]] || [[Granata Cesare]] | ||
|- | |- | ||
|- | |- | ||
| || || 14:45 || [[ | | || || 14:45 || | ||
[[Place 2022 Abstract Bioblast|Ca2+-induced mitochondrial adaptations in response to a single session of sprint interval training]] || [[Place Nicolas]] | |||
|- | |- | ||
|- | |- | ||
Line 68: | Line 72: | ||
|- | |- | ||
|- | |- | ||
| || || 16:00 || [[ | | || || 16:00 || [[Baglivo 2022 MitoFit-QC|Statistical analysis of instrumental reproducibility as internal quality control in high-resolution respirometry]] || [[Baglivo Eleonora]] | ||
|- | |- | ||
|- | |- | ||
| || || 16: | | || || 16:15 || [[Chicco 2022 MitoFit |Resolving the Rotenone Paradox: elucidating the Complexity of multi-substrate respirometry protocols]] || [[Chicco Adam J]] | ||
|- | |- | ||
|- | |- | ||
| || || 16: | | || || 16:30 || [[Cardoso 2022 Abstract Bioblast |Redox monitoring and respiration - a new horizon with the NextGen-O2k]] || [[Cardoso Luiza HD]] | ||
|- | |- | ||
|- | |- | ||
| || || 16: | | || || 16:45 || [[Garcia-Roves 2022 Abstract Bioblast|Tuning the assessment of coenzyme Q redox state and respiration in skeletal muscle permeabilized fibers]] || [[Garcia-Roves Pablo Miguel]] | ||
|- | |- | ||
|- | |- | ||
|} | |} | ||
Line 101: | Line 97: | ||
|- | |- | ||
|- | |- | ||
| || || 09:00 || [[Koopman 2022 Abstract Bioblast|The decylTPP mitochondria-targeting moiety lowers electron transport chain supercomplex levels in primary human skin fibroblasts]] || [[Koopman_Werner_JH]] | | || || 09:00 || [[Cecatto 2022 Abstract Bioblast|Mitochondrial calcium uptake capacity is lower than calcium retention capacity in the presence and absence of cyclosporin A]] || [[Cecatto Cristiane]] | ||
[[Koopman 2022 Abstract Bioblast|The decylTPP mitochondria-targeting moiety lowers electron transport chain supercomplex levels in primary human skin fibroblasts]] || [[Koopman_Werner_JH]] | |||
|- | |- | ||
|- | |- | ||
| || || 09:15 || [[Abed Rabbo 2022 MitoFit|NUBPL: a mitochondrial Complex I deficiency disorder]] || [[Stiban Johnny]] | | || || 09:15 || [[Serna 2022 Abstract Bioblast|Measuring mitochondrial Ca2+ efflux in isolated mitochondria and permeabilized cells]] || [[Serna Julian DC]] | ||
[[Abed Rabbo 2022 MitoFit|NUBPL: a mitochondrial Complex I deficiency disorder]] || [[Stiban Johnny]] | |||
|- | |- | ||
|- | |- | ||
| || || 09:30 || [[ | | || || 09:30 || [[Posch 2022 MitoFit|How to optimize respiratory models for SARS-CoV-2 research]] || [[Wilflingseder Doris]] | ||
|- | |- | ||
|- | |- | ||
| || || 09:45 || [[Torres-Quesada 2022 MitoFit Kinase|Kinase perturbations redirect mitochondrial function]] || [[Torres-Quesada Omar]] | | || || 09:45 || [[Heichler_2022_MitoFit|Physiometabolic RTCA on an automated platform for short and long term applications]] || [[Wolf Peter]] | ||
[[Torres-Quesada 2022 MitoFit Kinase|Kinase perturbations redirect mitochondrial function]] || [[Torres-Quesada Omar]] | |||
|- | |- | ||
|- | |- | ||
| || || | | || || 10:00 || [[Ecker 2022 Abstract Bioblast|Contextual Tissue Cytometry with AI – Functional Single Cell Analyses ''in-situ'']] || [[Ecker Rupert]] | ||
[[Stefan 2022 Abstract Bioblast|Tracking patient-mutation and lead-molecule driven alterations of kinase activity conformations]] || [[Stefan Eduard]] | |||
|- | |- | ||
|- | |- | ||
Line 122: | Line 122: | ||
|- | |- | ||
|- | |- | ||
| '''10:15 - 11:15''' || '''Coffee Break''' || || || | |||
| '''10: | |||
|- | |- | ||
|- | |- | ||
Line 137: | Line 128: | ||
|- | |- | ||
|- | |- | ||
| || || 11:15 || [[ | | || || 11:15 || [[Sobotka 2022 Abstract Bioblast| The Crabtree effect and clinical nutrition]] || [[Sobotka Lubos]] | ||
|- | |- | ||
|- | |- | ||
| || || 11:30 || [[ | | || || 11:30 || [[Moreno-Sanchez 2022 Abstract Bioblast| Estimation of energy pathway fluxes in cancer cells- beyond the Warburg effect]] || [[Moreno-Sanchez Rafael]] | ||
|- | |- | ||
|- | |- | ||
| || || 11:45 || [[ | | || || 11:45 || [[Porter 2022 Abstract Bioblast|A comparison of bioenergetics in human tongue pre-cancerous dysplastic oral keratinocytes and squamous cancer cells ]] || [[Porter Richard K]] | ||
|- | |- | ||
|- | |- | ||
| || || 12:00 || [[ | | || || 12:00 || [[Neuzil 2022 Abstract Bioblast|Metabolic switch utilizing ammonia supports proliferation in regenerating liver]] || [[Neuzil Jiri]] | ||
|- | |- | ||
|- | |- | ||
| || || 12:15 || [[Sumbalova 2022 Abstract Bioblast|Ubiquinol supplementation accelerates the recovery of mitochondrial health of patients with post COVID-19 syndrome on mountain spa rehabilitation]]|| [[Sumbalova Zuzana]] | | || || 12:15 || [[Lai 2022 Abstract Bioblast|Effect of isolation protocol of skeletal muscle mitochondrial subpopulations on bioenergetic function]] || [[Lai Nicola]] | ||
[[Sumbalova 2022 Abstract Bioblast|Ubiquinol supplementation accelerates the recovery of mitochondrial health of patients with post COVID-19 syndrome on mountain spa rehabilitation]]|| [[Sumbalova Zuzana]] | |||
|- | |- | ||
|- | |- | ||
| || || 12:20 || | | || || 12:20 || [[Lerink 2022 Abstract Bioblast|Renal respiratory conductance: a complex matter]] || [[Lerink Lente JS]] | ||
|- | |- | ||
|- | |- | ||
| || || 12:25 || [[Karabatsiakis 2022 Abstract Bioblast| Effects of eye-movement desensitization and reprocessing (EMDR) therapy on mitochondrial bioenergetics in immune cells from patients with post-traumatic stress disorder (PTSD): a pilot study.]] || [[Karabatsiakis Alexander]] | | || || 12:25 || [[Meszaros 2022 Abstract Bioblast|Pre-transplant mitochondrial respiration as a clinical prognostic marker during static cold storage and machine perfusion of the liver]] || [[Meszaros Andras]] | ||
[[Karabatsiakis 2022 Abstract Bioblast| Effects of eye-movement desensitization and reprocessing (EMDR) therapy on mitochondrial bioenergetics in immune cells from patients with post-traumatic stress disorder (PTSD): a pilot study.]] || [[Karabatsiakis Alexander]] | |||
|- | |- | ||
|- | |- | ||
| '''12:30 - 14:00''' || '''Lunch Break''' || || || | | '''12:30 - 14:00''' || '''Lunch Break - Orangerie''' || || || | ||
|- | |- | ||
|- | |- | ||
Line 164: | Line 158: | ||
|- | |- | ||
|- | |- | ||
| || || 14:00 || [[Dambrova 2022 Abstract Bioblast|Mitochondrial metabolites acylcarnitines: therapeutic potential and drug targets]]|| [[Dambrova Maija]] | | || || 14:00 || [[Eggelbusch 2022 Abstract Bioblast|Nutrient overload and insulin resistance precede reductions in mitochondrial respiration in skeletal muscle after bed rest]] || [[Eggelbusch Moritz]] | ||
[[Dambrova 2022 Abstract Bioblast|Mitochondrial metabolites acylcarnitines: therapeutic potential and drug targets]]|| [[Dambrova Maija]] | |||
|- | |- | ||
|- | |- | ||
| || || 14: | | || || 14:05 || [[Goulding 2022 Abstract Bioblast|Mitochondrial function is not impaired in type 1 diabetes but does not respond to 4-weeks endurance training]] || [[Goulding Richie P]] | ||
[[Aasander Frostner 2022 MitoFit|Towards a treatment for mitochondrial disease: Current compounds in clinical development] || [[Aasander Frostner Eleonor]] | |||
|- | |- | ||
|- | |- | ||
| || || 14: | | || || 14:10 || [[Chabi 2022 Abstract Bioblast|Coordination between MAMs, mitochondrial function and protein synthesis in exercised and myopathic muscles]] || [[Chabi Beatrice]] | ||
|- | |- | ||
|- | |- | ||
| || || 14: | | || || 14:15 || [[Irving 2022 Abstract Bioblast| Impact of nitric oxide promotors on mitochondrial bioenergetics in a murine model of Alzheimer's Disease]] || [[Irving Brian A]] | ||
|- | |- | ||
|- | |- | ||
| || || 14: | | || || 14:20 || | ||
|- | |- | ||
|- | |- | ||
Line 191: | Line 187: | ||
|- | |- | ||
|- | |- | ||
| || || 16:00 || | | || || 16:00 || | ||
|- | |- | ||
|- | |- | ||
| || || 16:15 || | | || || 16:15 || | ||
|- | |- | ||
|- | |- | ||
| || || 16:30 || | | || || 16:30 || | ||
|- | |- | ||
|- | |- | ||
| || || 16:45 || | | || || 16:45 || | ||
|- | |- | ||
|- | |- |
Revision as of 12:00, 15 June 2022
Program
2022-06-29 Day 1 of scientific presentations
2022-06-30 Day 2 of scientific presentations